Teva Pharma (TEVA) PT Raised to $8 at Piper Sandler
Tweet
Share
E-mailGet Alerts TEVA Hot Sheet
Price: $39.19 -2.56%
Rating Summary:
19 Buy, 20 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
19 Buy, 20 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
Piper Sandler analyst David Amsellem raised the price target on Teva Pharma (NYSE: TEVA) to $8.00 (from $7.00) while maintaining a Underweight rating.
You May Also Be Interested In
- Oppenheimer Starts Teva Pharma (TEVA) at Outperform
- Okta, Inc (OKTA) PT Raised to $230 at BMO Capital on 'AI and Virtuous Cycle Opportunity'
- Slate Grocery REIT (SGR-U:CN) (SRRTF) PT Lowered to $8.75 at Scotiabank
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
